Drugs / FK506E
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00909571 | Apr 2009 → Mar 2010 | — | Astellas Pharma Inc | Completed | No outcome recorded |
| Phase 3 | NCT02118896 | Feb 2003 → Oct 2009 | — | Astellas Pharma Europe Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FK506E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02118896 ↗ |
| Route | Oral | “oral” NCT00909571 ↗ |